The Journal of Practical Medicine ›› 2025, Vol. 41 ›› Issue (8): 1117-1122.doi: 10.3969/j.issn.1006-5725.2025.08.005
• Feature Reports:neuropathy • Previous Articles
Yingdao CHEN,Haining LI,Yuying LI,Qiping ZHANG,Bingsong LIANG,Guohui. LI()
Received:
2024-12-24
Online:
2025-04-25
Published:
2025-04-30
Contact:
Guohui. LI
E-mail:wzhhgh@163.com
CLC Number:
Yingdao CHEN,Haining LI,Yuying LI,Qiping ZHANG,Bingsong LIANG,Guohui. LI. The predictive value of serum miR-143-3p and miR-188-5p levels for poor prognosis in patients with acute cerebral infarction after thrombolysis[J]. The Journal of Practical Medicine, 2025, 41(8): 1117-1122.
Tab.5
Comparison of general data between good and poor prognosis groups"
一般资料 | 预后良好组(n = 81) | 预后不良组(n = 40) | t/χ2 值 | P值 |
---|---|---|---|---|
年龄/岁 | 66.28 ± 3.72 | 66.34 ± 3.85 | 0.083 | 0.934 |
男/女/例 | 48/33 | 25/15 | 0.118 | 0.732 |
体质量指数/(kg/m2) | 22.50 ± 3.04 | 22.43 ± 3.11 | 0.118 | 0.906 |
吸烟/[例(%)] | 20(24.69) | 11(27.50) | 0.111 | 0.739 |
饮酒/[例(%)] | 22(27.16) | 13(32.50) | 0.371 | 0.542 |
高血压/[例(%)] | 16(19.75) | 9(22.50) | 0.123 | 0.726 |
糖尿病/[例(%)] | 12(14.81) | 13(32.50) | 5.109 | 0.024 |
冠心病/[例(%)] | 13(16.05) | 8(20.00) | 0.291 | 0.589 |
心房颤动/[例(%)] | 11(13.58) | 7(17.50) | 0.325 | 0.569 |
发病至溶栓时间/min | 186.25 ± 35.26 | 223.68 ± 40.65 | 5.219 | < 0.001 |
入院时NIHSS评分/[例(%)] | 10.047 | 0.002 | ||
≥15分 | 13(16.05) | 17(42.50) | ||
< 15分 | 68(83.95) | 23(57.50) | ||
脑梗死面积/[例(%)] | 3.786 | 0.151 | ||
腔隙性 | 36(44.44) | 11(27.50) | ||
中面积 | 25(30.86) | 13(32.50) | ||
大面积 | 21(25.93) | 16(40.00) | ||
梗死部位/[例(%)] | 0.039 | 0.843 | ||
前循环 | 43(53.09) | 22(55.00) | ||
后循环 | 38(46.91) | 18(45.00) |
Tab.7
To analyze the influencing factors of poor prognosis in ACI patients after thrombolysis"
指标 | β | SE | Wald χ2 | P值 | OR | 95%CI |
---|---|---|---|---|---|---|
miR-143-3p | 0.987 | 0.301 | 10.759 | 0.001 | 2.684 | 1.488 ~ 4.842 |
miR-188-5p | -0.472 | 0.220 | 4.595 | 0.032 | 0.624 | 0.405 ~ 0.960 |
糖尿病 | 1.107 | 0.413 | 7.183 | 0.007 | 3.025 | 1.346 ~ 6.796 |
发病至溶栓时间 | 1.139 | 0.436 | 6.826 | 0.009 | 3.124 | 1.330 ~ 7.342 |
入院时NIHSS评分 | 1.392 | 0.480 | 11.632 | < 0.001 | 4.021 | 1.807 ~ 8.946 |
1 | 鲁国,李烁,闫福岭. 急性脑梗死治疗体位的研究进展[J]. 中华神经医学杂志,2018,17(5):537-540. |
2 | 梁菊萍,杨旸,董继存. 急性脑梗死患者流行病学调查及危险因素[J]. 中国老年学杂志, 2021, 41(12): 2484-2487. |
3 | 刘美霞,刘群会,朱祖欣,等. 急性脑梗死患者血清lncRNA SNHG14和miR-145-5p水平变化及其与疾病发生风险的关系[J]. 卒中与神经疾病, 2020, 27(1): 47-55. |
4 | 王爱明,梁勇,刘欣. 血清PTX3、Cav-1水平对急性脑梗死溶栓治疗患者近期预后的预测价值[J]. 山东医药, 2020, 60(19): 54-57. |
5 | 李彦岑,龙志鹏,张毅,等. 急性脑梗死病人血清miR-132和Ang-1水平变化及其与病情进展的关系[J]. 中西医结合心脑血管病杂志, 2023, 21(22): 4226-4230. |
6 |
SUN C, JIA N, LI R, et al. miR-143-3p inhibition promotes neuronal survival in an Alzheimer's disease cell model by targeting neuregulin-1[J]. Folia Neuropathol, 2020, 58(1): 10-21. doi:10.5114/fn.2020.94002
doi: 10.5114/fn.2020.94002 |
7 |
HOU D, PEI C, YU D, et al. miR-188-5p silencing improves cerebral ischemia/reperfusion injury by targeting Lin28a[J]. Metab Brain Dis, 2023, 38(7): 2327-2338. doi:10.1007/s11011-023-01273-9
doi: 10.1007/s11011-023-01273-9 |
8 |
中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组,中国急性缺血性脑卒中诊治指南 2018[J]. 中华神经科杂志, 2018, 51(9): 666-682. doi:10.3760/cma.j.issn.1006-7876.2018.09.004
doi: 10.3760/cma.j.issn.1006-7876.2018.09.004 |
9 | 冯海霞,丘红燕,任力杰,等. 轻型急性缺血性卒中rt-PA静脉溶栓的疗效和安全性研究[J]. 中风与神经疾病杂志, 2019, 36(3): 223-228. |
10 | 袁俊亮,张晓丹,李海英,等. smRSq量表在部分中国脑卒中人群中信度和效度的初步研究[J]. 临床神经病学杂志, 2016, 29(3): 161-163. |
11 | 王辉. 血清NSE、IMA及LPA对急性脑梗死患者预后的评估价值[J]. 脑与神经疾病杂志, 2020, 28(2):91-95. |
12 | 余婉琴. 静脉溶栓桥接机械取栓对急性脑梗死患者血清Lp-PLA2、NSE、PON-1水平的影响[J]. 实用中西医结合临床, 2021, 21(14): 51-52. |
13 | 吴志勇, 刘兵荣, 李彬, 等. 红细胞分布宽度对急性缺血性卒中静脉溶栓早期神经功能改善不良的预测作用[J]. 中国临床药理学与治疗学, 2023, 28(3): 307-314. |
14 |
GROTTA J C. Intravenous Thrombolysis for Acute Ischemic Stroke[J]. Continuum (Minneap Minn), 2023, 29(2):425-442. doi:10.1212/con.0000000000001207
doi: 10.1212/con.0000000000001207 |
15 |
PESCINI F, TORRICELLI S, SQUITIERI M, et al. Intravenous thrombolysis in CADASIL: Report of two cases and a systematic review[J]. Neurol Sci, 2023, 44(2):491-498. doi:10.1007/s10072-022-06449-2
doi: 10.1007/s10072-022-06449-2 |
16 |
DIENER C, KELLER A, MEESE E. Emerging concepts of miRNA therapeutics: From cells to clinic[J]. Trends Genet, 2022, 38(6):613-626. doi:10.1016/j.tig.2022.02.006
doi: 10.1016/j.tig.2022.02.006 |
17 | 王楠,赵东慧,刘彦佐. 急性脑梗死患者血清膜联蛋白A2和miR-9-5p的表达及其与病情严重程度的相关性[J]. 临床和实验医学杂志, 2024, 23(13): 1353-1356. |
18 |
MA Z, GAO Q, XIA W, et al. The role of miR-143-3p/FNDC1 axis on the progression of non-small cell lung cancer[J]. Eur J Histochem, 2023, 67(2): 3577-3582. doi:10.4081/ejh.2023.3577
doi: 10.4081/ejh.2023.3577 |
19 |
YAO P, LI Y L, CHEN Y, et al. Overexpression of long non-coding RNA Rian attenuates cell apoptosis from cerebral ischemia-reperfusion injury via Rian/miR-144-3p/GATA3 signaling[J]. Gene, 2020, 737(1):144411-144418. doi:10.1016/j.gene.2020.144411
doi: 10.1016/j.gene.2020.144411 |
20 | 陈伯勇,高庆春,王玉周,等. MicroRNA-143-3p对缺糖缺氧的大鼠脑微血管内皮细胞的保护作用及机制[J]. 卒中与神经疾病, 2020, 27(5): 561-566. |
21 | 罗丽,黄媛媛,唐翼. miR-143-3p对脑梗死大鼠神经细胞凋亡及Nrg-1/ErbB4信号通路的影响[J]. 脑与神经疾病杂志, 2022, 30(4): 203-209. |
22 |
XU J, YU D, BAI X, et al. Long non-coding RNA growth arrest specific transcript 5 acting as a sponge of MicroRNA-188-5p to regulate SMAD family member 2 expression promotes myocardial ischemia-reperfusion injury[J]. Bioengineered, 2021, 12(1): 6674-6686. doi:10.1080/21655979.2021.1957524
doi: 10.1080/21655979.2021.1957524 |
23 |
HOU D, PEI C, YU D, et al. miR-188-5p silencing improves cerebral ischemia/reperfusion injury by targeting Lin28a[J]. Metab Brain Dis, 2023, 38(7): 2327-2338. doi:10.1007/s11011-023-01273-9
doi: 10.1007/s11011-023-01273-9 |
24 | 尤志菲,刘心仪,孙康云. 血清GFAP、UCH-L1、NSE水平对急性脑梗死患者溶栓术后预后不良的预测价值[J]. 国际检验医学杂志, 2023, 44(19): 2419-2423. |
25 | 施罗炯,孙静. 血栓-炎症因子水平与老年急性脑梗死患者静脉溶栓预后的关系探讨[J]. 中风与神经疾病杂志, 2023, 40(12): 1101-1107. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||